Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
118 Leser
Artikel bewerten:
(0)

S&P Indices Announces Changes to U.S. Index

NEW YORK, June 7, 2012 /PRNewswire/ --S&P Indices will make the following changes to the S&P SmallCap 600 index:

  • Luminex Corp. (NASD: LMNX) will replace P.F. Chang's China Bistro, Inc. (NASD: PFCB) after the close of trading on Tuesday, June 12. Centerbridge Partners, L.P. is acquiring P.F. Chang's China Bistro in a deal expected to be completed soon pending final conditions.
  • Sabra Health Care REIT, Inc. (NASD: SBRA) will replace Kensey Nash Corp. (NASD: KNSY) after the close of trading on Friday, June 15. Kensey Nash is being acquired by Royal DSM in a deal expected to be completed soon pending final conditions.

Luminex engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. Headquartered in Austin, TX, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Life Sciences Tools & Services Sub-Industry index.

Sabra Health Care REIT owns and invests in real estate serving the healthcare industry. Headquartered in Irvine, CA, the company will be added to the S&P SmallCap 600 GICS Specialized REITs Sub-Industry index.

Following is a summary of the changes:

S&P SMALLCAP 600 INDEX - June 12, 2012


COMPANY

GICS ECONOMIC SECTOR

GICS SUB-INDUSTRY

ADDED

Luminex

Health Care

Life Science Tools & Services

DELETED

P.F. Chang's China Bistro

Consumer Discretionary

Restaurants

S&P SMALLCAP 600 INDEX - June 15, 2012


COMPANY

GICS ECONOMIC SECTOR

GICS SUB-INDUSTRY

ADDED

Sabra Health Care REIT

Financials

Specialized REITs

DELETED

Kensey Nash

Health Care

Health Care Equipment

About S&P Indices
S&P Indices, a leading brand of the McGraw-Hill Companies (NYSE: MHP), maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Over $1.45 trillion is directly indexed to our indices, which includes the S&P 500, the world's most followed stock market index, the S&P/Case-Shiller Home Price Indices, the leading measure of U.S. home prices, the S&P Global BMI, an index with approximately 11,000 constituents, the S&P GSCI, the industry's most closely watched commodities index, and the S&P National AMT-Free Municipal Bond Index, the premier investable index for U.S. municipal bonds. For more information, please visit: www.standardandpoors.com/indices.

It is not possible to invest directly in an index. S&P Indices does not sponsor, endorse, sell, or promote any S&P index-based investment product. This document does not constitute an offer of services in jurisdictions where S&P Indices or its affiliates do not have the necessary licenses. S&P Indices receives compensation in connection with licensing its indices to third parties.

For more information:
Dave Guarino
Communications
S&P Indices
dave_guarino@standardandpoors.com
212-438-1471

David Blitzer
Managing Director and Chairman of the Index Committee
S&P Indices
david_blitzer@standardandpoors.com
212-438-3907

SOURCE S&P Indices

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.